This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Podcast
Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking EP 199Guest: Alan Ehrlich MD, FAAFP
Music Credit: Richard Onorato
Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
Begin
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 11/23/2020
Expiration Date: 11/23/2021
Topics
Learning Objectives
- Assess the risk for malignancy in patients with microhematuria
- Describe a risk-based approach to evaluating microhematuria
Faculty
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Alan M. Ehrlich, MD, FAAFP
Associate Professor of Family Medicine and Community Health, University of Massachusetts Medical School
Executive Editor, DynaMed
Supporters and Partners
Commercial Supporter
Not Applicable
Education Partner
Not Applicable